NASDAQ:JKI - iShares Morningstar Mid-Cap Value ETF Stock Price, Forecast & News

iShares Morningstar Mid-Cap Value ETF's stock was trading at $124.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, JKI shares have decreased by 13.9% and is now trading at $107.32. View which stocks have been mosted impacted by Coronavirus.

iShares Morningstar Mid-Cap Value ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be paid a dividend of $1.4735 per share on Tuesday, March 31st. This represents a $5.89 dividend on an annualized basis and a dividend yield of 5.49%. The ex-dividend date is Wednesday, March 25th. This is a positive change from iShares Morningstar Mid-Cap Value ETF's previous quarterly dividend of $1.23. View iShares Morningstar Mid-Cap Value ETF's dividend history.

News articles about JKI stock have trended positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. iShares Morningstar Mid-Cap Value ETF earned a news sentiment score of 2.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutiShares Morningstar Mid-Cap Value ETF.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Morningstar Mid-Cap Value ETF investors own include Pzena Investment Management (PZN), Meredith (MDP), Mastercard (MA), Rhythm Pharmaceuticals (RYTM), PepsiCo (PEP), Forrester Research (FORR), Enphase Energy (ENPH), Crinetics Pharmaceuticals (CRNX), Reckitt Benckiser Group (RB) and Balfour Beatty (BBY).

iShares Morningstar Mid-Cap Value ETF trades on the NASDAQ under the ticker symbol "JKI."

iShares Morningstar Mid-Cap Value ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Equitable Holdings Inc. (4.59%), Matrix Trust Co (3.93%), UBS Group AG (2.47%), Bank of America Corp DE (1.73%), Ladenburg Thalmann Financial Services Inc. (1.54%) and Raymond James & Associates (1.06%).

JKI stock was sold by a variety of institutional investors in the last quarter, including Financial Advocates Investment Management, Envestnet Asset Management Inc., Cetera Advisor Networks LLC, CWM LLC, Bell Rock Capital LLC, Cambridge Investment Research Advisors Inc., GHP Investment Advisors Inc., and Courage Miller Partners LLC.

JKI stock was bought by a variety of institutional investors in the last quarter, including Equitable Holdings Inc., Thrivent Financial for Lutherans, Stifel Financial Corp, Bank of America Corp DE, Raymond James Financial Services Advisors Inc., Northwestern Mutual Wealth Management Co., Independent Advisor Alliance, and AE Wealth Management LLC.

Shares of JKI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of JKI stock can currently be purchased for approximately $107.32.

iShares Morningstar Mid-Cap Value ETF has a market capitalization of $300.50 million.  View additional information about iShares Morningstar Mid-Cap Value ETF.

The official website for iShares Morningstar Mid-Cap Value ETF is http://www.ishares.com/.

iShares Morningstar Mid-Cap Value ETF's mailing address is 45 Fremont Street, San Francisco, 94105, United States. The company can be reached via phone at +1-800-4742737.